Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
474 Views
eMediNexus 04 July 2021
Global Scenario
Coronavirus Cases: 184,219,548
Deaths: 3,987,081
Recovered: 168,600,124
ACTIVE CASES: 11,632,343
Serious/Critical Cases: 77,794
(Source: https://www.worldometers.info/coronavirus/; July 3, 2021)
# | Country,Other | TotalCases | NewCases | TotalDeaths | NewDeaths | TotalRecovered | NewRecovered | ActiveCases | Serious,Critical | Tot Cases/1M pop | Deaths/1M pop | TotalTests | Tests/1M pop | Population |
World | 184,219,548 | +379,777 | 3,987,081 | +7,166 | 168,600,124 | +330,454 | 11,632,343 | 77,794 | 23,634 | 511.5 | ||||
1 | 34,588,176 | +7,978 | 621,255 | +96 | 29,087,421 | +14,540 | 4,879,500 | 3,798 | 103,884 | 1,866 | 507,601,876 | 1,524,558 | ||
2 | 30,544,485 | +43,296 | 402,015 | +947 | 29,650,169 | +52,431 | 492,301 | 8,944 | 21,918 | 288 | 416,416,463 | 298,805 | ||
3 | 18,742,025 | +54,556 | 523,699 | +1,631 | 17,033,808 | +44,457 | 1,184,518 | 8,318 | 87,549 | 2,446 | 54,003,112 | 252,262 | ||
4 | 5,783,654 | +3,006 | 111,152 | +17 | 5,629,530 | +2,831 | 42,972 | 1,102 | 88,410 | 1,699 | 93,999,106 | 1,436,888 | ||
5 | 5,585,799 | +24,439 | 137,262 | +697 | 5,053,417 | +17,899 | 395,120 | 2,300 | 38,260 | 940 | 150,700,000 | 1,032,211 | ||
6 | 5,440,368 | +4,537 | 49,874 | +45 | 5,310,769 | +4,913 | 79,725 | 702 | 63,818 | 585 | 61,455,218 | 720,894 | ||
7 | 4,879,616 | +24,885 | 128,207 | +18 | 4,332,181 | +2,412 | 419,228 | 300 | 71,503 | 1,879 | 214,786,845 | 3,147,342 | ||
8 | 4,526,473 | +14,034 | 95,594 | +212 | 4,136,824 | +22,728 | 294,055 | 5,667 | 99,240 | 2,096 | 16,983,108 | 372,342 | ||
9 | 4,324,230 | +26,928 | 108,314 | +591 | 4,021,254 | +27,603 | 194,662 | 8,155 | 84,086 | 2,106 | 20,282,143 | 394,391 | ||
10 | 4,262,511 | +932 | 127,637 | +22 | 4,089,298 | +3,110 | 45,576 | 204 | 70,604 | 2,114 | 72,199,045 | 1,195,893 |
(Source: https://www.worldometers.info/coronavirus/; July 3, 2021)
Indian Scenario
3rd July: New Cases 43296, New Deaths 947, Total Cases 30544485, Total Deaths 402015, Active Cases 492301
2nd July: New Cases 47252, New Deaths 797, Total Cases 30501189, Total Deaths 401068, Active Cases 502383
1st July: New Cases 43360, New Deaths 796, Total Cases 30453937, Total Deaths 400271, Active Cases 517579
30th June: New Cases 48878, New Deaths 991, Total Cases 30410577, Total Deaths 399475, Active Cases 529580
29th June: New Cases 45699, New Deaths 816, Total Cases 30361699, Total Deaths 398484, Active Cases 543718
28th June: New Cases 37037, New Deaths 907, Total Cases 30316000, Total Deaths 397668, Active Cases 559124
27th June: New Cases 46643, New Deaths 981, Total Cases 30278963, Total Deaths 396761, Active Cases 579942
26th June: New Cases 49851, New Deaths 1256, Total Cases 30232320, Total Deaths 395780, Active Cases 593205
25th June: New Cases 49052, New Deaths 1186, Total Cases 30182469, Total Deaths 394524 , Active Cases 602386
24th June: New Cases 51248, New Deaths 965, Total Cases 30133417, Total Deaths 393338, Active Cases 619739
23rd June: New Cases 54319, New Deaths 978, Total Cases 30082169, Total Deaths 392014, Active Cases 633546
22nd June: New Cases 54393, New Deaths 1129, Total Cases 30027850, Total Deaths 390691, Active Cases 649848
21st June: New Cases 39096, New Deaths 846, Total Cases 29973457, Total Deaths 389268, Active Cases 670998
20th June: New Cases 53009, New Deaths 1113, Total Cases 29934361, Total Deaths 388164, Active Cases 709668
19th June: New Cases 58588, New Deaths 1239, Total Cases 29881352, Total Deaths 386740, Active Cases 736165
18th June: New Cases 60800, New Deaths 1269, Total Cases 29822764, Total Deaths 385167, Active Cases 766718
17th June: New Cases 62409, New Deaths 1310, Total Cases 29761964, Total Deaths 383521, Active Cases 805422
16th June: New Cases 67294, New Deaths 1411, Total Cases 29699555, Total Deaths 381931, Active Cases 833080
(Source: https://www.worldometers.info/coronavirus/)
Cases
COVID-19 Variants
SARS-CoV-2 Variants of Concern
New WHO Label | Pango lineage | GISAID clade/lineage
| Next strain clade | Earliest documented samples
| Date of designation | Key mutations in spike protein |
Alpha | B.1.1.7 | GRY (formerly GR/501Y.V1) | 20I (V1) | UK, September 2020 | 18th December, 2020 | N501Y (RBD), 69/70 deletion, 144Y deletion, P681H (S1/S2 furin cleavage site |
Beta | B.1.351 | GR/501Y.V2 | 20H (V2) | South Africa, May 2020 | 18th December, 2020 | N501Y, K417N, E484K, 241/242/243 deletion |
Gamma | P1 | GR/501Y.V3 | 20J (V1) | Brazil, November 2020 | 11th January, 2021 | N501Y, K417T, E484K |
Delta* | B.1.617.2 | G/478K.V1 | 21A | India, October 2020 | 4th April, 2021 (VOI) 11th May, 2021 (VOC) | E484Q, L452R |
(Source: WHO)
* A new “Delta plus” variant (B.1.617.2.1 or AY.1) has been formed due to a new mutation K417N in the Delta variant. The Union Health Ministry has said that the Delta Plus variant is now a Variant of Concern in India.
SARS-CoV-2 Variants of Interest
New WHO Label | Pango lineage | GISAID clade/lineage
| Next strain clade | Earliest documented samples
| Date of designation |
Epsilon | B.1.427/B.1.429 | GH/452R.V1 | 21C | California USA, March 2020 | 5th March, 2021 |
Zeta | P.2 | GR/484K.V2 | 20B/S.484K | Brazil, April 2020 | 17th March, 2021 |
Eta | B.1.525 | G/484K.V3 | 21D | Multiple countries, December 2020 | 17th March, 2021 |
Theta | P.3 | GR/1092K.V1 | 21E | Philippines, January 2021 | 24th March, 2021 |
Iota | B.1.526 | GH/253G.V1 | 21F | New York USA, November 2020 | 24th March, 2021 |
Kappa | B.1.617.1 | G/452R.V3 | 21B | India, October 2020 | 4th April, 2021 |
Lambda | C.37 | G/452Q.V1 | 20D | Peru, August 2020 | 14th June, 2021 |
(Source: WHO)
Hybrid of Indian and UK COVID-19 variants: Vietnam has uncovered a new Covid-19 variant combining characteristics of the two existing variants first found in India and the UK, which can spread quickly by air. The concentration of virus in the throat fluid increases rapidly and spreads very strongly to the surrounding environment. The WHO has said that there is no new hybrid strain. The strain detected in Vietnam is part of delta strain first detected in India.
Some consequences of emerging variants
Variants of concern might require one or more appropriate public health actions, such as notification to WHO under the International Health Regulations, reporting to CDC, local or regional efforts to control spread, increased testing, or research to determine the effectiveness of vaccines and treatments against the variant. Based on the characteristics of the variant, additional considerations may include the development of new diagnostics or the modification of vaccines or treatments (CDC).
India predictions: Formulas for better understanding of data
COVID Sutra
COVID-19 pandemic is due to SARS 2 Beta-coronavirus (different from SARS 1 where spread was only in serious cases); Causes mild or atypical illness in 82%, moderate to severe illness in 15%, critical illness in 3% and death in 2.3% cases (15% of admitted serious cases, 71% with comorbidity< Male > Females); affects all but predominantly males (56%, 87% aged 30-79, 10% aged < 20, 3% aged > 80); with variable incubation period days (2-14; mean 5.2 days); mean time to symptoms 5 days; mean time to pneumonia 9 days, mean time to death 14 days, Mean Time to CT changes 4 Days, Reproductive Number R0 1.5 to 3 (Flu 1.2 and SARS 2), Origin Possibly from Bats (Mammal); spreads through the air (by inhalation of air carrying very small fine droplets and aerosol particles, human to human transmission via large and small droplets or touching inanimate surfaces contaminated with virus . Enters through MM of eyes, nose or mouth and the spike protein gets attached to the ACE2 receptors, which are found in organs throughout the body (heart muscle, CNS, kidneys, blood vessels, liver). Once the virus enters, it turns the cell into a factory, making millions of copies of itself, which are then breathed or coughed out and infect others.
10 Sutras to remember
Some more numbers
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}